An Update Regarding the Coronavirus
From Dr. Martin Dubravec on June 11, 2021:

Fact:
More questions are being raised with regard to COVID-19 vaccinations and reporting of the rate of COVID-19 infection in patients who have received the vaccines.  These cases are called “breakthrough cases”.    The CDC reported that it will not be keeping track of people who get COVID-19 after they have been vaccinated unless they are hospitalized or die of COVID-19.  In part because of this the CDC admitted that “the number of reported COVID-19 vaccine breakthrough cases is likely a substantial undercount of all SARS-CoV-2 infections among fully vaccinated persons”.

Source:  https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e3.htm

Comment/Opinion:
The CDC is once again compromising its credibility (or further ruining it) by vastly undercounting the number of patients who get COVID-19 after vaccination.  How are we to know how effective the vaccines are if we are not accurately looking at those who have gotten sick?  The overwhelming majority of patients who get COVID-19 never get hospitalized.  Therefore, most of the breakthrough cases will not be accounted for.  Could there be concerns that the vaccines are not very effective (or effective at all)?  If people are to trust what comes out of the CDC, then the data coming from the CDC should be accurate.  At least we can be thankful that they have described their own lack of accuracy with regard to the data they produce.

#TruthMatters

Update from:

“Physicians for Informed Consent Updates Its Pfizer-BioNTech COVID-19 Vaccine Risk Statement for Healthcare Providers and Families

Educational document highlights Pfizer clinical trial finding that 1 in 9 vaccinated adolescents suffered a severe adverse event

NEWPORT BEACH, CALIF. – June 8, 2021

Physicians for Informed Consent (PIC), an educational nonprofit organization focused on science and statistics, recently published an update of its Pfizer-BioNTech COVID-19 Vaccine Risk Statement, which includes key questions and answers about the clinical trial data. The Pfizer COVID-19 vaccine is the first COVID-19 vaccine to receive expanded emergency use authorization (EUA) for adolescents; however, the vaccine is still not FDA-approved.

The PIC Pfizer-BioNTech COVID-19 Vaccine Risk Statement (VRS) answers important questions such as:

• How effective is the vaccine in children, adults, and the elderly?
• Is the vaccine effective in preventing hospitalizations and deaths?
• Is the vaccine effective and safer than the COVID-19 virus?
• Does the vaccine prevent the spread of the virus?

The updated document indicates that for children 12 to 15 years of age, the Pfizer COVID-19 vaccine clinical trial found the overall incidence of severe adverse events during the two-month observation period to be 10.7% or 1 in 9 in the vaccinated group. In addition, the incidence of COVID-19 in the unvaccinated group was 1.6%; therefore, there were almost seven times more severe adverse events observed in the vaccinated group than there were COVID-19 cases in the unvaccinated group.

Furthermore, since only about 1,100 vaccinated children 12 to 15 years of age were observed in the clinical trial, there were not enough children included in the trial to be able to prove the vaccine is safer than the disease in children 12 to 15 years of age. The chance of a child 0 to 17 years of age contracting SARS-CoV-2 and dying from COVID-19 is 1 in 290,000.

Anyone considering the COVID-19 vaccine must be informed of known and potential benefits and risks, and the extent to which benefits and risks are unknown. For example, the clinical trial did not have enough statistical power to measure the vaccine’s ability to prevent hospitalizations and deaths, and did not assess if the vaccine prevents asymptomatic infection or spread (transmission) of the virus.

“PIC is committed to making the available data more accessible to everyone researching COVID-19 vaccines,” said Dr. Shira Miller, PIC founder and president. “Our concise, reader-friendly document assists healthcare providers and parents in making informed decisions for the children in their care.”

Physicians for Informed Consent’s body of physicians, scientists, statisticians and healthcare workers is trusted by both patients and practitioners for providing scientific data on infectious diseases and vaccines. To download your copy of the VRS “Pfizer-BioNTech COVID-19 Vaccine: Short-Term Efficacy & Safety Data,” visit physiciansforinformedconsent.org/covid-19-vaccines.

CLICK HERE to view press release on PRWeb.

An Update Regarding the Coronavirus Epidemic

• predominantly in adolescents and young adults,
• more often in males than females,
• more often following dose 2 than dose 1, and
• typically within 4 days after vaccination.

• With regard to people under 16 years of age, “the CDC acknowledges they face 0% risk of mortality from COVID-19 statistically.”

• “In approximately  January  of  2020,  the media  began creating  and circulating news stories that seemed  designed to  generate  panic, regarding  a new and deadly disease that could kill  us all. This was odd given that the estimated fatality rate at the time was between 2-4%.  By contrast, tuberculosis  has a  fatality  rate  of  approximately 10%, the original SARS virus  had a fatality  rate of approximately 9%,  and the  MERS  virus had  a fatality  rate of  approximately 30%  –  all  had similar rates of  spread.   The  actual  COVID-19 statistics  present  a  very different picture than the  one  painted  by  the  media  –  a  fatality rate of  0.2%  globally, which drops  to 0.03%  for persons under  age 70,  which  is  comparable  to  the  yearly  flu.   Further, statistically, the fatality risk is limited to the elderly population.

• “Department of Health and Human Services Data   are now  showing  that  95% of  deaths  classed as  “COVID-19  deaths” involve  an  average of  four  additional comorbidities.  This misattribution of the cause of death undoubtedly stems from the substantial government subsidies paid to incentivize such misreporting of COVID-19 deaths.”

• “Manufacturer inserts furnished  with  the  PCR  test  products  include  disclaimers  stating  that the PCR  tests should  NOT  be  used  to diagnose COVID-19.  This  is consistent  with the warning issued  by  the  Nobel  Prize  winning  inventor of  the PCR test  that such tests  are not appropriate for diagnosing disease.”

• “The  CDC  has  announced it will no  longer compile and report data showing the  total number of vaccinated who subsequently contract COVID-19: “[We are] transitioning to  reporting only patients with COVID-19 vaccine  breakthrough infection that  were hospitalized  or died  to help maximize the quality of the data collected.”  There appears to be an agenda to protect the myths about the vaccine, rather than the public.”

• “It is important to note that the Pfizer and Moderna EUA COVID-19 experimental injections were only shown to reduce symptoms – not block transmission.”

 An Update Regarding the Coronavirus Epidemic

Dr. Martin Dubravec

May 7, 2021

 This information is being provided for patients and others interested in updates regarding the Coronavirus (COVID-19, Sars-CoV-2) epidemic.  Facts are provided.  My comments and opinions are listed separately.  The goals of these updates have been to help the community in keeping informed of the epidemic from a local medical perspective.  As a clinical immunologist, I believe it is vital that information be shared with regard to this important issue.  If you would like to receive this information via Email, feel free to Email us at aasc1234@protonmail.com .  Please note we have transitioning to a new Email address as listed here.  (Our old Email address was aasc1234@hotmail.com .)

Fact:

 Between April 5 and May 4, we have seen a 71% drop in positive COVID-19 PCR test results in Michigan.  Nationwide, COVID-19 positive PCR tests remain at a low but steady level.

 Source:  https://www.michigan.gov/coronavirus/0,9753,7-406-98163_98173—,00.html

https://www.worldometers.info/coronavirus/country/us/

Comment/Opinion:

 Our office has seen a sharp decline in patients with COVID-19 symptoms and positive COVID-19 PCR tests over the past 2 weeks.  This is consistent with statewide data that shows a sharp decline in COVID-19 cases.  Local hospitals continue to see patients with COVID-19 positive tests, however.  This can be expected to decline as hospitalizations lag behind positive COVID-19 test rates by 7-10 days.

Fact:

 Concerns have been raised regarding the safety of the experimental gene therapy COVID-19 vaccines in pregnancy.  A recent article suggests no significant problems with these experimental gene therapy COVID-19 vaccines in pregnancy.  Further analysis of the article reveals the opposite.

 Source:  https://www.nejm.org/doi/full/10.1056/NEJMoa2104983?query=featured_coronavirus

 Comment/Opinion:

 The safety of experimental gene therapy COVID-19 vaccines in pregnancy is of major concern.  The above article suggests these vaccines are safe.  However, on closer inspection of the data, we see that the rates of reactions to the vaccines are very possibly much higher.  For example, the article uses Vaccine Adverse Event Reporting System (VAERS) data to show a low amount of reported reactivity to the experimental gene therapy COVID-19 vaccines.  But it has been shown that VAERS data only represents about 1% of the total amount of reactions to vaccines.  This is because the VAERS system is voluntary and most reactions are not documented by health care providers due to a lack of time or interest.  The authors of the study also admit that “there is probably substantial underreporting of pregnancy- and neonatal-specific adverse events.”  Therefore, the rates of reaction to these experimental gene therapy COVID-19 vaccines may be very high. 

 Because of these concerns, many practitioners are recommending against the use of experimental gene therapy COVID-19 vaccines in pregnancy.  Our office will continue to closely monitor reactions to these experimental gene therapy COVID-19 vaccines.

Fact:

 The Association of American Physicians and Surgeons has released a statement demanding a stop to forced vaccination of college students:

 Open Letter from Physicians to Universities: Allow Students Back Without COVID Vaccine Mandate

 Dear Deans, Governing Boards and Trustees,

On behalf of the Association of American Physicians and Surgeons, I am writing to ask you to reconsider your new policy mandating COVID-19 vaccination of students prior to returning to campus.[i] Institutions of higher learning are divided on this issue.[ii] ,[iii] Although, at first glance, the policy may seem prudent, it coerces students into bearing unneeded and unknown risk and is at heart contrary to the bedrock medical principle of informed consent.

There are multiple reasons to reverse your policy. I ask you to consider the following:

1. Young adults are a healthy and immunologically competent and vibrant group that is at, “extraordinary low risk for COVID-19 morbidity and mortality.”[iv]
2. College and University students, however, are under significant mental health strain already from COVID-19 fears, circumstances, distance learning problems and the imposition of government health policy restrictions.[v]
3. Even though the FDA granted Emergency Use Authorization (EUA) for three COVID-19 vaccines, they are not FDA approved to treat, cure or prevent any disease at this time.  Clinical trials will continue for at least two years before the FDA can even consider approval of these vaccines as effective and safe.
4. The COVID-19 vaccines on the market in the U.S., mRNA (Moderna and Pfizer) and DNA (Johnson & Johnson – Janssen), have caused notable side effects, pathology and even death (>2300 deaths per VAERS as of  April 20, 2021). These adverse reactions result in absence from school and work, hospital visits, and even loss of life.[vi]
5. College-age women may be at unique risk for adverse events following administration of the experimental COVID vaccinations currently available. According to the CDC, all cases of life-threatening blood clots, subsequent to receiving the J&J vaccine, reported so far in the United States, occurred in younger women.[vii]  The vast majority of cases of anaphylaxis have also occurred in women.[viii] In addition, “women are reporting having irregular menstrual cycles after getting the coronavirus vaccine,”[ix] and 95 miscarriages have been reported to the U.S. Vaccine Adverse Effects Reporting System (VAERS) following COVID vaccination as of April 24, 2021.[x]
6. Recent research data demonstrates that the spike protein, present on the SARS-CoV-2 virus and the induced primary mechanism of action of COVID-19 vaccines, are the primary cause of disease, infirmity, hospitalization and death.[xi]
7. Students who have had self-limited cases of COVID-19 already possess antibodies, activated B-cells, activated T-cells (detectable by lab testing).  This durable, long-term immunity would not only prevent them from getting recurrent COVID-19, but would also represent herd immunity to protect others in the college or university community.[xii],[xiii]
8. COVID-19 convalescent students may be harmed by college and university policy requiring COVID-19 vaccines.[xiv] They already have extensive immunity and would be likely harmed from a forced confrontation with COVID-19 vaccine induced spike protein causing autoimmune reactions leading to illness and possible death.[xv]
9. Students and their families may justifiably believe these policies discriminate against individuals who aren’t candidates for this vaccine, have pre-existing conditions, previous COVID-19 disease, cite religious objections, or are otherwise exercising their freewill choosing not to participate in this optional vaccine experiment. Refer to the Nuremberg code from WWII, which requires individuals, “to be able to exercise free power of choice, without the intervention of any element of force….”[xvi]
10. Institutional policies that permit faculty to choose or refuse vaccination, but do not allow students the same options, raise equal protection constitutional issues.
11. The ADA, Americans with Disabilities Act, requires “reasonable accommodations,” be provided based on an individual’s own unique health situation.  This includes rejection of an experimental vaccine intervention which may exacerbate known health problems and thereby cause harm.
12. Colleges and Universities should consider whether they might be liable for damages, poor health outcomes, and loss of life due to mandatory COVID-19 vaccination policies.[xvii]
13. “Positive cases,” as defined by laboratory testing alone, may be false positive testing errors or asymptomatic infection that is not clinically proven to spread disease.
14. Ambulatory outpatient early treatment for SARS-CoV-2 infection / COVID-19 has been demonstrated effective in adults.[xviii]
15. Informed consent is the standard for all medical interventions. The FDA factsheet for the healthcare provider reads, “The recipient or their caregiver has the option to accept or refuse (Pfizer-BioNTech) vaccine.”

Please reverse your decision to mandate experimental COVID-19 vaccines before more students are harmed and make the vaccines rightfully optional. Both unvaccinated and vaccinated students should be permitted on campus. Thank you for your time and attention. We would appreciate hearing back from you as soon as possible and welcome further discussion with you and other leaders at your institution.

Sincerely,

Paul M. Kempen, M.D., Ph.D. – AAPS President (2021)

Source:  https://aapsonline.org/open-letter-from-physicians-to-universities-reverse-covid-vaccine-mandates/

Comment/Opinion:

 A one size fits all approach to vaccination is not scientific or rational.  No two patients are alike.  Decisions to receive vaccination should be the choice of the patient.  Certain medications and therapies are not indicated or safe in certain patients; vaccines are no exception to this.   

 The currently available experimental gene therapy vaccines are allowed for emergency use but have not been shown by the FDA to be safe or effective.  This does not mean they may not end up being safe and effective, but preliminary data has shown that these vaccines can produce severe side effects.  They have not been studied in pregnant patients prior to being launched.  They were not studied in those over 55 years of age or those who have had COVID-19.  The safety of these vaccines has not been looked at in children or in pregnant patients prior to being massively pushed on the American population.

 College students have virtually no risk of death from COVID-19.  Furthermore, herd immunity can be best established when those with little to no risk of severe illness from COVID-19 actually get exposed to the virus.  People who have COVID-19 have been naturally vaccinated; they don’t need a vaccine (at least for 6-12 months) to protect them from illness.  What is concerning is that these individuals may be at significantly increased risk of bad reactions to the vaccine if they have already had COVID-19 and then receive an experimental gene therapy COVID-19 vaccine.

 Not surprisingly, our office has seen a marked increase in vaccine reactions to the experimental gene therapy vaccines for COVID-19.  Since these vaccines did not undergo research and analysis of any significant extent prior to being mass produced and administered to millions of people, the results of this are being seen.  (The Moderna vaccine did not even undergo any animal trials prior to being approved in humans.)  Because the overall survival rate of COVID-19 in the American population is over 99%, there is no need to rush into vaccination.

An Update Regarding the Coronavirus Epidemic

Dr. Martin Dubravec

April 23, 2021

 This information is being provided for patients and others interested in updates regarding the Coronavirus (COVID-19, Sars-CoV-2) epidemic.  Facts are provided.  My comments and opinions are listed separately.  The goals of these updates have been to help the community in keeping informed of the epidemic from a local medical perspective.  As a clinical immunologist, I believe it is vital that information be shared with regard to this important issue.  If you would like to receive this information via Email, feel free to Email us at aasc1234@protonmail.com . 

 Fact:

 After a peak in January 2021, nationwide cases of people with a positive COVID-19 PCR test have decreased by approximately 70%.  In Michigan, a peak in cases over the past two months occurred on April 5.  A rise in hospitalizations then followed.  Local hospitals have reported record numbers of positive COVID-19 patients.  In our office, we have seen a decline in patients reporting COVID-19 symptoms.  This mirrors statewide data over the past week.

 Source:  https://www.worldometers.info/coronavirus/country/us/

https://www.michigan.gov/coronavirus/0,9753,7-406-98163_98173—,00.html

 Comment/Opinion:

 There is good news regarding COVID-19 on a nationwide basis.  We are also possibly beginning to see a decline in cases locally.  We had a peak in activity in early March, then a decline for a short period of time, only for it to increase again earlier this month.  Hopefully, this is the beginning of a sustained decrease in patients with active COVID-19.

 No one can predict with certainty what will happen with this virus in the future.  As more people become exposed to the virus, we can hope and expect that herd immunity will continue to cause cases to decrease as people become naturally immune to the disease.

There are many who hope that the new experimental gene therapy vaccines will speed up herd immunity.  Preliminary data has not yet borne this out.

Early treatment remains the key to addressing this virus.  Patients with COVID-19 symptoms (flu-like symptoms) should seek treatment as soon as possible (within 3 days), as the earlier one is treated, the greater the likelihood that treatment will work.  No treatment is 100% effective for all patients, but data regarding early treatment (hydroxychloroquine or Ivermectin) shows an 80-85% success rate in preventing hospitalization from COVID-19.

Fact:

 Data regarding the effectiveness of currently available experimental gene therapy vaccines is lacking.  The safety of these vaccines is also not known.  Preliminary data is beginning to come in regarding the safety and effectiveness of these therapies which have received conditional use approval from the US government.

 Source:  https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/

 https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html

 https://www.wsj.com/articles/j-j-privately-asked-rival-covid-19-vaccine-makers-to-probe-clotting-risks-11618570802

Comment/Opinion:

 The currently available COVID-19 vaccines (conditional use, emergency use authorization experimental gene therapy vaccines) have been in use with no significant data to show their effectiveness or safety.  As an example, people with prior COVID-19 infection were excluded from the very limited human trials conducted by Pfizer and Moderna in the run up to the vaccines being given to millions of Americans.  The Moderna vaccine underwent no animal trials prior to being approved for human use.  Data stating that these vaccines are “95% effective” are at best misleading:  the “effectiveness” of any vaccine is not measured at 6 or 8 weeks after vaccination.  It can only be measured at years after vaccination.  All of the currently available COVID-19 experimental gene therapy vaccines should be considered to carry the risk of producing blood clots, as they have been reported in all of the vaccines. 

Our office has seen numerous vaccine reactions to the currently available COVID-19 vaccines.  Although this is not settled science but only an observation of one clinic that treats these patients, it is nonetheless remarkable that we have had so many reports of adverse reactions to these vaccines.  Life-threatening reactions and deaths from these experimental vaccines are rare when compared to the number of people who have received the vaccines.  However, the same statistics are present when looking at the number of people who have died from COVID-19 compared to the number of people who have had the illness.  The risk of death from COVID in Americans is less than 0.03%.  The overall survival rate of COVID-19 is 99.98%.

We have also received reports of businesses where numerous employees are sick with COVID-19 even though they have been vaccinated.  In one location, no less than five employees, vaccinated in January 2021, have recently been infected with COVID-19.

 It has been this office’s recommendation that no one under the age of 70 should receive the currently available experimental gene therapy COVID-19 vaccines pending further data showing their safety.  In those over the age of 70, it is also questionable whether the risk of vaccination is worth it in an otherwise healthy person.  It is my hope that these vaccines will be shown to be safe and effective. No one should be coerced or pressured to receive or not receive any vaccination.

 It is my recommendation that any patients who decide to be vaccinated should first be tested for COVID-19 IgG antibodies.  If they have antibodies, they should seriously reconsider their decision for vaccination as they carry an increased risk of severe reactivity to the vaccine. 

 Patients at risk for severe illness to COVID-19 can consider preventative therapy with either hydroxychloroquine or Ivermectin taken weekly or every two weeks.  Data shows that these medications can prevent COVID-19 infection in many, but not all, patients.  These medications carry a track record of safety that far exceeds that of the currently available vaccines for COVID-19.

 Is there a safe alternative?  Sanofi is currently working on a protein-based vaccine that may be safe for use as it uses longstanding technology that has been utilized for years in other vaccines.  ( )  It is not gene therapy.  This office will continue to monitor this situation closely.